Attorneys on both sides continue to dispute the breadth of medical record production and the timing for expert witness disclosures
Patients may also experience acid reflux, blood sugar fluctuations, and severe cases can lead to malnutrition or bezoar formation
The big pharma company announced it will initiate several Phase III trials for elecoglipron, which was licensed from Eccogene in 2023
Most importantly, doses below 2.5 mg weekly have not been studied for efficacy in weight management, meaning there is no evidence that microdosing produces clinically meaningful weight loss
The clinic provides comprehensive weight programs, including the well-known B12 with fat burner in Cedar Park, TX
Most of the drug typically leaves the body about 2530 days after the last injection